Pyoderma gangrenosum: Clinicopathologic correlation and proposed diagnostic criteria

International Journal of Dermatology

Volumn 43, Issue 11, 2004, Pages 790-800

  Su, W P Daniel ^a,b   Davis, Mark D P ^a,b   Weenig, Roger H ^a,b   Powell, Frank C ^a,b   Perry, Harold O ^a,b  

^a MAYO CLINIC   (United States)

^b MATER PRIVATE HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BENZOYL PEROXIDE; CHLORAMBUCIL; CHLORMETHINE; CLOFAZIMINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 16; INTERLEUKIN 8; LYMECYCLINE; MELPHALAN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; MEZLOCILLIN; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POTASSIUM IODIDE; PREDNISONE; RIFAMPICIN; SULFAPYRIDINE; TACROLIMUS; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALIGNANT NEOPLASTIC DISEASE; PATHOGENESIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PYODERMA GANGRENOSUM; REVIEW; SKIN BIOPSY; SKIN INFECTION; VASCULITIS;

HUMANS; PYODERMA GANGRENOSUM;

EID: 8844219701     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02128.x     Document Type: Review

References (147)

1. Weenig RH, Davis MD, Dahl PR, et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 2002; 347: 1412-1418.
2. Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma (echthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syph 1930; 22: 655-680.
3. Brunsting LA, Underwood LJ. Pyoderma vegetans in association with chronic ulcerative colitis. Arch Dermatol Syph 1949; 60: 161-171.
4. Perry HO, Brunsting LA. Pyoderma gangrenosum: a clinical study of nineteen cases. AMA Arch Dermatol 1957; 75: 380-386.
5. Muller SA. Pyoderma gangrenosum (editorial). Minn Med 1966; 49: 91-93.
6. Perry HO, Didisheim P. Consideration of the etiology of pyoderma gangrenosum. In: Jadassohn W, Schirren CG, eds. 13th International Congress of Dermatology, Munich, 1967, Vol. 2. Berlin: Springer-Verlag, 1968: 1208-1212 [in German].
7. Perry HO. Pyoderma gangrenosum. South Med J 1969; 62 899-908.
8. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 1972; 106: 901-905.
9. Massa MC, Doyle JA. Cutaneous cryptococcosis simulating pyoderma gangrenosum. J Am Acad Dermatol 1981; 5: 32-36.
10. Perry HO. Pyoderma gangrenosum. Australas J Dermatol 1982; 23: 53-61.
11. Powell FC, Schroeter AL, Perry HO, et al. Direct immunofluorescence in pyoderma gangrenosum. Br J Dermatol 1983; 108: 287-293.
12. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol 1983; 119 468-472.
13. Powell FC, Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol 1984; 120: 757-761.
14. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum and sarcoidosis. Arch Dermatol 1984; 120: 959-960.
15. Finan MC, Su WPD. Hairy cell leukemia and pyoderma gangrenosum (letter). J Am Acad Dermatol 1985; 13: 301-302.
16. Su WPD, Schroeter AL, Perry HO. Pyoderma gangrenosum: a clinicopathologic study of 63 cases (Abstract). South Med J 1986; 79: 11.
17. Su W, Schroeter AL, Perry HO, et al. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 1986; 13: 323-330.
18. Smith KC, Su WP, Leiferman KM. Cromolyn sodium in 2% aqueous solution under an occlusive hydrocolloid dressing may be effective adjunctive treatment in management of pyoderma gangrenosum. J Am Acad Dermatol 1987; 17: 509-511.
19. Maule WF, Perniciaro C, Ortego TJ. Cavitating ulcers: pyoderma gangrenosum of the anal canal? Gastroenterology 1988; 95: 1158-1159.
20. Su WPD. Pyoderma gangrenosum. In: Greer KE, ed. Common Problems in Dermatology. Chicago: Year Book Medical Publishers, 1988: 330-334.
21. Wilson-Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988; 18: 511-521.
22. Cole HG, Nelson RL, Peters MS. Pyoderma gangrenosum and adrenocortical carcinoma. Cutis 1989; 44: 205-208.
23. Misra SP, Singh SK, Chari ST, et al. Pyoderma gangrenosum in ulcerative colitis. J Assoc Physicians India 1991; 39: 570-571.
24. Harmon CB, Su WP, Peters MS. Cutaneous aspergillosis complicating pyoderma gangrenosum. J Am Acad Dermatol 1993; 29 656-658.
25. Daoud MS, Gibson LE, Muller SA. Cutaneous Wegener's granulomatosis presenting as pyoderma gangrenosum-like ulceration. Eur J Dermatol 1995; 5: 23-27.
26. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.
27. Lindor NM, Arsenault TM, Solomon H, et al. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997; 72 611-615.
28. Tremaine WJ. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD. Inflamm Bowel Dis 1998; 4: 68-69.
29. Yeon HB, Lindor NM, Seidman JG, et al. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 2000; 66: 1443-1448.
30. Goudet P, Dozois RR, Kelly KA, et al. Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy. Dig Surg 2001; 18: 51-55.
31. Dahl MV, Bridges AG. Intravenous immune globulin: fighting antibodies with antibodies. J Am Acad Dermatol 2001; 45: 775-783.
32. Geller JD, Peters MS, Su WP. Cutaneous mucormycosis resembling superficial granulomatous pyoderma in an immunocompetent host. J Am Acad Dermatol 1993; 29: 462-465.
33. Schroeter AL. Superficial granulomatous pyoderma. Mayo Clin Proc 1989; 64: 123-124.
34. Quimby SR, Gibson LE, Winkelmann RK. Superficial granulomatous pyoderma: clinicopathologic spectrum. Mayo Clin Proc 1989; 64: 37-43.
35. Aram H. Malignant pyoderma. J Am Acad Dermatol 1987; 16: 392.
36. Dicken CH. Malignant pyoderma. J Am Acad Dermatol 1985; 13: 1021-1025.
37. Powell FC, Winkelmann RK. Malignant pyoderma. Br J Dermatol 1983; 109: 597-603.
38. Salassa JR, Winkelmann RK, McDonald TJ. Malignant pyoderma. Otolaryngol Head Neck Surg 1981; 89: 917-922.
39. Perry HO, Winkelmann RK, Muller SA, et al. Malignant pyodermas. Arch Dermatol 1968; 98: 561-576.
40. Schlesinger IH, Farber GA. Cutaneous ulceration resembling pyoderma gangrenosum in the primary antiphospholipid syndrome: a report of two additional cases and review of the literature. J a State Med Soc 1995; 147: 357-361.
41. Schmid M-H, Hary C, Marstaller B, et al. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome. Eur J Dermatol 1998; 8: 45-47.
42. Babe KS Jr, Gross AS, Leyva WH, et al. Pyoderma gangrenosum associated with antiphospholipid antibodies. Int J Dermatol 1992; 31: 588-590.
43. Freedman AM, Phelps RG, Lebwohl M. Pyoderma gangrenosum associated with anticardiolipin antibodies in a pregnant patient. Int J Dermatol 1997; 36: 205-207.
44. Chacek S, MacGregor-Gooch J, Halabe-Cherem J, et al. Pyoderma gangrenosum and extensive caval thrombosis associated with the antiphospholipid syndrome: a case report. Angiology 1998; 49: 157-160.
45. Grob JJ, Bonerandi JJ. Cutaneous manifestations associated with the presence of the lupus anticoagulant: a report of two cases and review of the literature. J Am Acad Dermatol 1986; 15: 211-219.
46. Selva A, Ordi J, Roca M, et al. Pyoderma-gangraenosum-like ulcers associated with lupus anticoagulant. Dermatology 1994; 189: 182-184.
47. Scheinman PL. Klippel-Trénaunay-Weber syndrome mimicking pyoderma gangrenosum. Int J Dermatol 1995; 34: 717-719.
48. White JC, Adam BA, Lau KS, et al. Cryoimmunoglobulin IgGκ with microtubular ultrastructure associated with pyoderma gangrenosum. J Pathol 1976; 120: 25-33.
49. Daoud MS, Gibson LE, DeRemee RA, et al. Cutaneous Wegener's granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol 1994; 31: 605-612.
50. Micali G, Cook B, Ronan S, et al. Cephalic pyoderma gangrenosum (PG)-like lesions as a presenting sign of Wegener's granulomatosis. Int J Dermatol 1994; 33: 477-480.
51. Handfield-Jones SE, Parker SC, Fenton DA, et al. Wegener's granulomatosis presenting as pyoderma gangrenosum. Clin Exp Dermatol 1992; 17: 197-200.
52. Thomas RH, Payne CM, Black MM. Wegener's granulomatosis presenting as pyoderma gangrenosum. Clin Exp Dermatol 1982; 7 523-527.
53. Smith JB, Shenefelt PD, Soto O, et al. Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa. J Am Acad Dermatol 1996; 34: 901-903.
54. Perniciaro CV, Winkelmann RK, Hunder GG. Cutaneous manifestations of Takayasu's arteritis: a clinicopathologic correlation. J Am Acad Dermatol 1987; 17: 998-1005.
55. Frances C, Boisnic S, Bletry O, et al. Cutaneous manifestations of Takayasu arteritis: a retrospective study of 80 cases. Dermatologica 1990; 181: 266-272.
56. Thomas R, Vuitch F, Lakhanpal S. Angiocentric T cell lymphoma masquerading as cutaneous vasculitis. J Rheumatol 1994; 21: 760-762.
57. Camisa C, Helm TN, Sexton C, et al. Ki-1-positive anaplastic large-cell lymphoma can mimic benign dermatoses. J Am Acad Dermatol 1993; 29: 696-700.
58. Ho KK, Browne A, Fitzgibbons J, et al. Mycosis fungoides bullosa simulating pyoderma gangrenosum. Br J Dermatol 2000; 142: 124-127.
59. Vose JM, Armitage JO, Duggan M, et al. Pyoderma gangrenosum or cutaneous lymphoma: a difficult clinical diagnosis. Cutis 1988; 42: 335-337.
60. Helm KF, Peters MS, Tefferi A, et al. Pyoderma gangrenosum-like ulcer in a patient with large granular lymphocytic leukemia. J Am Acad Dermatol 1992; 27: 868-871.
61. Torok L, Kirschner A, Gurzo M, et al. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis. Eur J Dermatol 2000; 10: 463-465.
62. Norris JF, Marshall TL, Byrne JP. Histiocytosis X in an adult mimicking pyoderma gangrenosum. Clin Exp Dermatol 1984; 9: 388-392.
63. Stroud JD. Sporotrichosis presenting as pyoderma gangrenosum. Arch Dermatol 1968; 97: 667-670.
64. Liao WQ, Zang YL, Shao JZ. Sporotrichosis presenting as pyoderma gangrenosum. Mycopathologia 1991; 116: 165-168.
65. Spiers EM, Hendrick SJ, Jorizzo JL, et al. Sporotrichosis masquerading as pyoderma gangrenosum. Arch Dermatol 1986; 122: 691-694.
66. Lesher JL Jr, Fitch MH, Dunlap DB. Subclinical hypothyroidism during potassium iodide therapy for lymphocutaneous sporotrichosis. Cutis 1994; 53: 128-130.
67. Brown TS, Callen JP. Atypical presentation of herpes simplex virus in a patient with chronic lymphocytic leukemia. Cutis 1999; 64: 123-125.
68. Wahba A, Cohen HA. Herpes simplex virus isolation from pyoderma gangrenosum lesions in a patient with chronic lymphatic leukemia. Dermatologica 1979; 158: 373-378.
69. Matsui M, Ohtoshi E, Yamaoka J, et al. Cutaneous tuberculosis and pyoderma gangrenosum. Int J Dermatol 2000; 39 38-40.
70. Sunarwan I. A case of cutaneous amoebiasis. Dermatologica 1975; 151: 253-256.
71. Liao WQ, Yao ZR, Li ZQ, et al. Pyoderma gangraenosum caused by Rhizopus arrhizus. Mycoses 1995; 38: 75-77.
72. Chiewchanvit S, Mahanupab P, Baosoung V, et al. Uncommon manifestations of opportunistic infections in an HIV infected patient. J Med Assoc Thai 1998; 81: 923-926.
73. Parent DJ, Krafft T, Noel JC, et al. Cutaneous Munchausen syndrome with presentation simulating pyoderma gangrenosum. J Am Acad Dermatol 1994; 31: 1072-1074.
74. Barrett AP, Buckley DJ. Covert self-mutilation of oral tissues and skin by mechanical and chemical means. Oral Surg Oral Med Oral Pathol 1988; 65: 685-688.
75. David M, Ingber A, Sandbank M, et al. Bromoderma caused by carbromalhydroxyzine hydrochloride. Biomed Pharmacother 1983; 37: 298-300.
76. Peterson LL. Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers. J Am Acad Dermatol 1984; 10: 379-384.
77. Rees RS, Fields JP, King LE Jr. Do brown recluse spider bites induce pyoderma gangrenosum? South Med J 1985; 78: 283-287.
78. Hoover EL, Williams W, Koger L, et al. Pseudoepitheliomatous hyperplasia and pyoderma gangrenosum after a brown recluse spider bite. South Med J 1990; 83: 243-246.
79. von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997; 137: 1000-1005.
80. Huang W, McNeely MC. Neutrophilic tissue reactions. Adv Dermatol 1998; 13: 33-63.
81. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55: 173-186.
82. Powell FC, Collins S. Pyoderma gangrenosum. Clin Dermatol 2000; 18: 283-293.
83. O'Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 1978; 114: 1061-1064.
84. Burgess NA, Lari JL. Pyoderma gangrenosum with large circumferential perianal skin loss in a child. Br J Clin Pract 1991; 45: 223-224.
85. al-Rimawi HS, Abuekteish FM, Daoud AS, et al. Familial pyoderma gangrenosum presenting in infancy. Eur J Pediatr 1996; 155: 759-762.
86. Graham JA, Hansen KK, Rabinowitz LG, et al. Pyoderma gangrenosum in infants and children. Pediatr Dermatol 1994; 11 10-17.
87. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55: 401-412.
88. Philpott JA Jr, Goltz RW, Park RK. Pyoderma gangrenosum, rheumatoid arthritis, and diabetes mellitus. Arch Dermatol 1966; 94: 732-738.
89. Lazarus GS, Goldsmith LA, Rocklin RE, et al. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol 1972; 105: 46-51.
90. Stolman LP, Rosenthal D, Yaworsky R, et al. Pyoderma gangrenosum and rheumatoid arthritis. Arch Dermatol 1975; 111 1020-1023.
91. Jablonska S, Stachow A, Dabrowska H. Relationships between pyoderma gangrenosum and myeloma [in French]. Ann Dermatol Syphiligr 1967; 94: 121-132.
92. Zabel M. Pyoderma gangrenosum with IgG-paraproteinemia in plasmacytoma [in German]. Hautarzt 1976; 27: 603-605.
93. Kohl PK, Hartschuh W, Tilgen W, et al. Pyoderma gangrenosum followed by subcorneal pustular dermatosis in a patient with IgA paraproteinemia. J Am Acad Dermatol 1991; 24: 325-328.
94. Wayte JA, Rogers S, Powell FC. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy. Australas J Dermatol 1995; 36: 21-23.
95. Klein S, Mayer L, Present DH, et al. Extraintestinal manifestations in patients with diverticulitis. Ann Intern Med 1988; 108: 700-702.
96. Vignon-Pennamen MD, Zelinsky-Gurung A, Janssen F, et al. Pyoderma gangrenosum with pulmonary involvement. Arch Dermatol 1989; 125: 1239-1242.
97. Kasuga I, Yanagisawa N, Takeo C, et al. Multiple pulmonary nodules in association with pyoderma gangrenosum. Respir Med 1997; 91: 493-495.
98. Brown TS, Marshall GS, Callen JP. Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 2000; 43: 108-112.
99. Mahood JM, Sneddon IB. Pyoderma gangrenosum complicating non-Hodgkin's lymphoma. Br J Dermatol 1980; 102: 223-225.
100. Cox NH, White SI, Walton S, et al. Pyoderma gangrenosum associated with polycythaemia rubra vera. Clin Exp Dermatol 1987; 12: 375-377.
101. Cartwright PH, Rowell NR. Hairy-cell leukaemia presenting with pyoderma gangrenosum. Clin Exp Dermatol 1987; 12: 451-452.
102. van de Kerkhof PC, de Vaan GA, Holland R. Pyoderma gangrenosum in acute myeloid leukaemia during immunosuppression. Eur J Pediatr 1988; 148: 34-36.
103. Ho KK, Otridge BW, Vandenberg E, et al. Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia. J Am Acad Dermatol 1992; 27: 804-808.
104. Duguid CM, O'Loughlin S, Otridge B, et al. Paraneoplastic pyoderma gangrenosum. Australas J Dermatol 1993; 34: 17-22.
105. Haim S, Friedman-Birnbaum R. Pyoderma gangrenosum in immunosuppressed patients. Dermatologica 1976; 153: 44-48.
106. Burns DA, Sarkany I. Active chronic hepatitis and pyoderma gangrenosum: report of a case. Clin Exp Dermatol 1979; 4: 465-469.
107. Hickman JG, Lazarus GS. Pyoderma gangrenosum: a reappraisal of associated systemic diseases. Br J Dermatol 1980; 102: 235-237.
108. Green LK, Hebert AA, Jorizzo JL, et al. Pyoderma gangrenosum and chronic persistent hepatitis. J Am Acad Dermatol 1985; 13: 892-897.
109. Venning VA, Ryan TJ. Subcorneal pustular dermatosis followed by pyoderma gangrenosum. Br J Dermatol 1986; 115: 117-118.
110. Hughes BR, Cunliffe WJ. Development of folliculitis and pyoderma gangrenosum in association with abdominal pain in a patient following treatment with isotretinoin. Br J Dermatol 1990; 122 683-687.
111. Pinto GM, Cabecas MA, Riscado M, et al. Pyoderma gangrenosum associated with systemic lupus erythematosus: response to pulse steroid therapy. J Am Acad Dermatol 1991; 24: 818-821.
112. Goulden V, Bond L, Highet AS. Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria. Clin Exp Dermatol 1994; 19: 271-273.
113. Clark HH, Cohen PR. Pyoderma gangrenosum in an HIV-infected patient. J Am Acad Dermatol 1995; 32: 912-914.
114. Adachi Y, Kindzelskii AL, Cookingham G, et al. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 1998; 111: 259-268.
115. Oka M, Berking C, Nesbit M, et al. Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 2000; 80 595-604.
116. Shands JW Jr, Flowers FP, Hill HM, et al. Pyoderma gangrenosum in a kindred: precipitation by surgery or mild physical trauma. J Am Acad Dermatol 1987; 16: 931-934.
117. Moschella SL. Pyoderma gangrenosum: a patient successfully treated with intralesional injections of steroid. Arch Dermatol 1967; 95: 121-123.
118. Peachy RD. Proceedings: pyoderma gangrenosum of scalp. Br J Dermatol 1974; 90: 106-108.
119. Vereecken P, Wautrecht JC, De Dobbeleer G, et al. A case of pyoderma gangrenosum stabilized with lymecycline, topical benzoyl peroxide and treated by autograft. Dermatology 1997; 195: 50-51.
120. Michaelsson G, Molin L, Ohmann S, et al. Clofazimine: a new agent for the treatment of pyoderma gangrenosum. Arch Dermatol 1976; 112: 344-349.
121. Soto LD. Diaminodiphenylsulfone and steroids in the treatment of pyoderma gangrenosum. Int J Dermatol 1970; 9: 293-300.
122. Tay CH. Pyoderma gangrenosum and leukemia (letter). Arch Dermatol 1973; 108: 580-581.
123. Lynch WS, Bergfeld WF. Pyoderma gangrenosum responsive to minocycline hydrochloride. Cutis 1978; 21: 535-538.
124. Kang S, Dover JS. Successful treatment of eruptive pyoderma gangrenosum with intravenous vancomycin and mezlocillin. Br J Dermatol 1990; 123: 389-393.
125. Richardson JB, Callen JP. Pyoderma gangrenosum treated successfully with potassium iodide. J Am Acad Dermatol 1993; 28 1005-1007.
126. Sanders CJ, Hulsman RF. Successful treatment of pyoderma gangrenosum with topical 5-ammosalicylic acid. Cutis 1993; 51 262-264.
127. Maldonado N, Torres VM, Mendez-Cashion D, et al. Pyoderma gangrenosum treated with 6-mercaptopurine and followed by acute leukemia. J Pediatr 1968; 72: 409-414.
128. Schopf E, Schulz HJ, Schulz KH. Azathioprine treatment of ulcerative dermatitis (pyoderma gangrenosum) [in German]. Hautarzt 1969; 20: 558-563.
129. Callen JP, Case JD, Sager D. Chlorambucil: an effective corticosteroid-sparing therapy for pyoderma gangrenosum. J Am Acad Dermatol 1989; 21: 515-519.
130. Crawford SE, Sherman R, Favara B. Pyoderma gangrenosum with response to cyclophosphamide therapy. J Pediatr 1967; 71: 255-258.
131. Curley RK, Macfarlane AW, Vickers CF. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol 1985; 113: 601-604.
132. Theissen U, Luger TA, Schwarz T. Successful topical administration of cyclosporin A in pyoderma. gangraenosum [in German]. Hautarzt 1996; 47: 132-135.
133. Teitel AD. Treatment of pyoderma gangrenosum with methotrexate. Cutis 1996; 57: 326-328.
134. Hohenleutner U, Mohr VD, Michel S, et al. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum. Lancet 1997; 350: 1748.
135. Tsele E, Yu RC, Chu AC. Pyoderma gangrenosum: response to topical nitrogen mustard. Clin Exp Dermatol 1992; 17: 437-440.
136. Abu-Elmagd K, Jegasothy BV, Ackerman CD, et al. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991; 23: 3328-3329.
137. Schuppe HC, Homey B, Assmann T, et al. Topical tacrolimus for pyoderma gangrenosum (letter). Lancet 1998; 351 832.
138. Ortonne JP, Thivolet J, Chouvet B, et al. Pyoderma gangrenosum, ovarian carcinoma treated with melphalan and acute myelomonocytic leukaemia: report of one case and literature review [in French]. Ann Dermatol Venereol 1979; 106: 251-256.
139. Tan MH, Gordon M, Lebwohl O, et al. Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor α monoclonal antibody. Arch Dermatol 2000; 137: 930-933.
140. Sanchez Roman J, Castillo Palma MJ, Ocana Medina C, et al. The treatment of cyclosporine A-resistant pyoderma gangrenosum with recombinant interferon α-2 [in Spanish]. Med Clin (Barc) 1995; 104: 517-518.
141. Gupta AK, Shear NH, Sander DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol 1995; 32: 140-142.
142. Clayton R, Feiwel M, Valdimarsson H. Pyoderma gangrenosum with cellular immunity deficit treated with plasmaphoresis and leukocyte transfusion. Br J Dermatol 1976; 95 (Suppl. 14): 67-68.
143. Venencie PY, Saurat JH. Pyoderma gangrenosum in a child: treatment with thalidomide [in French]. Ann Pediatr (Paris) 1982; 29: 67-69.
144. Paolini O, Hebuterne X, Flory P, et al. Treatment of pyoderma gangrenosum with colchicine. Lancet 1995; 345: 1057-1058.
145. Kanekura T, Usuki K, Kanzaki T. Nicotine for pyoderma gangrenosum. Lancet 1995; 345: 1058.
146. Tamir A, Landau M, Brenner S. Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum. Dermatology 1996; 192: 252-254.
147. Lim KK, Su WP, Schroeter AL, et al. Cyclosporine in the treatment of dermatologic disease: an update. Mayo Clin Proc 1996; 71: 1181-1191.